Check Your Eligibility

Answer a few questions to see if you may qualify for this trial.

Step 1 of 8

Have you been diagnosed with one of these specific cancer types: GIST, small cell lung cancer (SCLC), adrenocortical cancer (ACC), uveal melanoma, neuroendocrine tumor (NET), chromophobe renal cell carcinoma (ChRCC), or clear cell renal cell carcinoma (ccRCC)?

This study is designed specifically for these cancer types because they express c-Kit, the target of this drug. Your cancer must be confirmed by tissue biopsy or cell analysis and be advanced, spread to other areas, or unable to be surgically removed.

Show original medical criteria

Histologically or cytologically confirmed locally advanced, metastatic, and/or unresectable GIST, SCLC, ACC, uveal melanoma, NET, ChRCC or ccRCC

This is informational only — not medical advice. Always discuss eligibility with your oncologist.